Drug profile · INN
perfluorohexyloctane
NOVATEARS
perfluorohexyloctane (NOVATEARS) is a unknown. Associated with Lacuna Pharma Pty Ltd. Route of administration: ophthalmic. Current US regulatory status: approved.
Drug details — perfluorohexyloctane
- US status
- approved
- Class
- —
- Route
- OPHTHALMIC
- Patents
- 0
- Programs
- 4
- Data quality
- 0.84
Quick answer
perfluorohexyloctane (NOVATEARS) is a unknown. Associated with Lacuna Pharma Pty Ltd. Route of administration: ophthalmic. Current US regulatory status: approved.
Key facts
Mechanism of action
Unknown
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| TGA | approved | — |
Pipeline programs
Frequently asked questions
What is perfluorohexyloctane?
perfluorohexyloctane (NOVATEARS) is a unknown. Associated with Lacuna Pharma Pty Ltd. Route of administration: ophthalmic. Current US regulatory status: approved.
What is the brand name for perfluorohexyloctane?
NOVATEARS is a marketed brand name for perfluorohexyloctane. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of perfluorohexyloctane?
perfluorohexyloctane has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.